File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Biomarker analysis of randomized controlled trial (RCT) of adjuvant chemotherapy (CT) using plasma EBV DNA to identify patients (pts) at higher risk of relapse after radiotherapy (RT) or chemoradiation (CRT) in nasopharyngeal cancer (NPC)

TitleBiomarker analysis of randomized controlled trial (RCT) of adjuvant chemotherapy (CT) using plasma EBV DNA to identify patients (pts) at higher risk of relapse after radiotherapy (RT) or chemoradiation (CRT) in nasopharyngeal cancer (NPC)
Authors
Hui, E. P.Chan, A. T.C.Ngan, R. K.C.Tung, S. Y.Cheng, A. C.K.Ng, W. T.Lee, V. H.Ma, B.Cheng, H. C.Wong, F. C.S.Loong, H. H.Tong, M.Poon, D. M.Ahuja, A. T.King, A. D.Wang, K.Mo, F.Zee, B. C.Chan, K. C.A.Lo, Y. M.D.
Issue Date2017
Citation
Annals of Oncology, 2017, v. 28, suppl. 10, p. x100 How to Cite?
DOI: http://dx.doi.org/10.1093/annonc/mdx665
Persistent Identifierhttp://hdl.handle.net/10722/282122
ISSN
0923-7534
2021 Impact Factor: 51.769
2020 SCImago Journal Rankings: 7.954

 

DC FieldValueLanguage
dc.contributor.authorHui, E. P.-
dc.contributor.authorChan, A. T.C.-
dc.contributor.authorNgan, R. K.C.-
dc.contributor.authorTung, S. Y.-
dc.contributor.authorCheng, A. C.K.-
dc.contributor.authorNg, W. T.-
dc.contributor.authorLee, V. H.-
dc.contributor.authorMa, B.-
dc.contributor.authorCheng, H. C.-
dc.contributor.authorWong, F. C.S.-
dc.contributor.authorLoong, H. H.-
dc.contributor.authorTong, M.-
dc.contributor.authorPoon, D. M.-
dc.contributor.authorAhuja, A. T.-
dc.contributor.authorKing, A. D.-
dc.contributor.authorWang, K.-
dc.contributor.authorMo, F.-
dc.contributor.authorZee, B. C.-
dc.contributor.authorChan, K. C.A.-
dc.contributor.authorLo, Y. M.D.-
dc.date.accessioned2020-04-29T07:36:07Z-
dc.date.available2020-04-29T07:36:07Z-
dc.date.issued2017-
dc.identifier.citationAnnals of Oncology, 2017, v. 28, suppl. 10, p. x100-
dc.identifier.issn0923-7534-
dc.identifier.urihttp://hdl.handle.net/10722/282122-
dc.languageeng-
dc.relation.ispartofAnnals of Oncology-
dc.titleBiomarker analysis of randomized controlled trial (RCT) of adjuvant chemotherapy (CT) using plasma EBV DNA to identify patients (pts) at higher risk of relapse after radiotherapy (RT) or chemoradiation (CRT) in nasopharyngeal cancer (NPC)-
dc.typeConference_Paper-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1093/annonc/mdx665-
dc.identifier.scopuseid_2-s2.0-85083630526-
dc.identifier.volume28-
dc.identifier.issuesuppl. 10-
dc.identifier.spagex100-
dc.identifier.epagex100-
dc.identifier.eissn1569-8041-
dc.identifier.issnl0923-7534-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats